Sanofi (SNY) Financial Analysis & Valuation | Quarter Chart

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty ... more
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marke... more

Company facts

Reported company information and share structure.

Company Share structure
Market Cap$105.16BExchangeNASDAQ
SectorHealthcareIndustryDrug Manufacturers - General
CountryFRCEOBelén Garijo López
IPO Date2002-07-01CAGR8.69%
Employees82,878Websitewww.sanofi.com
Div. Yield8.29%Payout Ratio46%
Buy Back Yield0.03%Total Yield8.32%
SNY chart loading...

Key metrics

Reported fundamentals and market-derived technical indicators.

Fundamentals Technicals
EV$113.36BP/E9.44Forward P/E8.43PEG-1.64
P/S1.02P/B0.82P/CF2.94P/FCF3.17
Sales$55.02BSales 1Y8.18%Sales 3Y2.5%Sales 5Y28.2%
EPS$4.59EPS 1Y-27.51%EPS 3Y-41.62%EPS 5Y-59.96%
Sales QoQ-7.87%EPS QoQ-145.89%Sales QoQ Avg2.17%EPS QoQ Avg-73.05%
Gross Margin71.62%Operating Margin25.09%Profit Margin17.59%ROCE15.07%
ROA8%ROE14%Altman Z Score1.6Piotroski Score6
Current Ratio1.01Quick Ratio0.22Cash Ratio0.18Op. CF Ratio0.11
Debt/Equity0.27Debt/Assets0.16Lt Debt/Equity0.19Lt Debt/Cap.0.14
Intrst Cov.27.98Inventory Turnover0.71Asset Turnover0.46Receivables Turnover122.17
Enterprise Value$113.36BP/E Ratio9.44
Forward P/E8.43PEG Ratio-1.64
P/S Ratio1.02P/B Ratio0.82
P/CF Ratio2.94P/FCF Ratio3.17
EPS$4.59EPS Growth 1Y-27.51%
EPS Growth 3Y-41.62%EPS Growth 5Y-59.96%
Revenue Growth 1Y8.18%Gross Margin0.72%
Operating Margin0.25%Profit Margin0.18%
ROE0.14%ROA0.08%
ROCE0.15%Current Ratio1.01
Quick Ratio0.22Cash Ratio0.18
Debt/Equity0.27Interest Coverage27.98
Altman Z Score1.6Piotroski Score6

Sanofi (SNY) valuation & financials

Sanofi (SNY) has a market capitalization of $105.16B and trades at a price-to-earnings ratio of 9.4. It operates in the Healthcare sector (Drug Manufacturers - General).

Sanofi's revenue grew +8.2% over the last year.

Sanofi's next earnings report is scheduled for July 30, 2026 before market open; analysts estimate EPS of $1.09.

📈 Analysts estimate SNY EPS of $1.09 for the upcoming quarter. See Sanofi revenue & EPS analyst forecasts for the next four quarters with Quarter Chart Premium.

Sanofi (SNY) — frequently asked questions

When does Sanofi (SNY) report earnings next?

Sanofi is expected to report earnings on July 30, 2026 before market open. Analysts estimate EPS of $1.09.

What is Sanofi's market cap?

Sanofi (SNY) has a market capitalization of $105.16B.

What is SNY's P/E ratio?

Sanofi trades at a price-to-earnings ratio of 9.4, with trailing twelve-month EPS of $4.59.

How fast is Sanofi growing?

Sanofi's revenue grew +8.2% over the last year.

Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)